(Q34219375)

31 July 2017

1 reference

title

Probiotics in inflamatory bowel disease (English)

1 reference

31 July 2017

0 references

Shanahan F

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

48

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

609

1 reference

Probiotics and inflammatory bowel disease: is there a scientific rationale?

31 July 2017

cites work

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728287

Nutrient tasting and signaling mechanisms in the gut V. Mechanisms of immunologic sensation of intestinal contents

5 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728287

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

5 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728287

Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

5 July 2018

1 reference

12 December 2020

Immunity and probiotics

1 reference

12 December 2020

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

1 reference

12 December 2020

Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative?

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.48.5.609

1 reference

31 July 2017

1 reference

31 July 2017

1 reference